Clinical studies in COVID-related olfactory disorders: Review of an institutional experience.

Theresa TharakanDorina KallogjeriJay F Piccirillo

Published in: World journal of otorhinolaryngology - head and neck surgery (2024)

Initial intervention trials for COVID-related OD have shown potential for improving subjective and objective olfactory outcomes. However, there remains no gold standard treatment that definitively outperforms placebo in controlled trials. Therefore, continued investigation of novel therapeutic strategies for COVID-related OD is necessary to maximize olfactory outcomes for affected patients.

Keyphrases

coronavirus disease
sars cov
randomized controlled trial
ejection fraction
newly diagnosed
type diabetes
clinical trial
respiratory syndrome coronavirus
depressive symptoms
physical activity
insulin resistance
double blind
open label